GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $38.10 $43.42 Thursday, 18th Apr 2024 CLDX stock ended at $38.53. This is 2.78% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.89% from a day low at $38.31 to a day high of $39.80.
90 days $34.65 $53.18
52 weeks $22.11 $53.18

Historical Celldex Therapeutics prices

Date Open High Low Close Volume
2023-09-13 $27.66 $27.89 $27.32 $27.42 288 950
2023-09-12 $27.50 $28.04 $27.17 $27.63 246 495
2023-09-11 $28.77 $28.93 $27.46 $27.53 308 190
2023-09-08 $28.41 $29.61 $28.24 $28.77 337 214
2023-09-07 $28.04 $28.60 $27.36 $28.31 549 202
2023-09-06 $28.15 $28.53 $27.62 $28.21 246 767
2023-09-05 $28.62 $29.04 $27.60 $28.03 480 177
2023-09-01 $28.10 $29.20 $28.10 $28.81 308 896
2023-08-31 $27.73 $28.03 $27.25 $27.90 501 204
2023-08-30 $28.17 $28.32 $27.52 $27.74 508 181
2023-08-29 $28.13 $28.49 $27.86 $28.18 466 283
2023-08-28 $28.46 $28.73 $27.97 $28.30 444 831
2023-08-25 $28.82 $28.85 $28.29 $28.54 768 458
2023-08-24 $29.05 $29.05 $28.00 $28.69 912 948
2023-08-23 $29.01 $29.69 $28.98 $29.13 540 747
2023-08-22 $30.00 $30.29 $28.73 $28.98 1 189 118
2023-08-21 $30.13 $30.86 $29.86 $30.57 376 047
2023-08-18 $29.45 $30.37 $28.88 $30.19 454 818
2023-08-17 $30.16 $30.45 $29.81 $29.84 357 276
2023-08-16 $31.44 $31.51 $30.09 $30.15 404 075
2023-08-15 $31.07 $31.48 $30.85 $31.43 328 140
2023-08-14 $29.87 $31.10 $29.35 $31.07 338 184
2023-08-11 $30.49 $31.17 $30.03 $30.23 341 865
2023-08-10 $30.65 $32.08 $30.10 $30.55 455 894
2023-08-09 $28.11 $30.53 $27.52 $30.52 890 690
Click to get the best stock tips daily for free!

About Celldex Therapeutics

Celldex Therapeutics Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity... CLDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT